Results 121 to 130 of about 1,940,460 (362)
Pathobiology of Secondary Immune Thrombocytopenia
Primary immune thrombocytopenic purpura (ITP) remains a diagnosis of exclusion both from nonimmune causes of thrombocytopenia and immune thrombocytopenia that develops in the context of other disorders (secondary immune thrombocytopenia). The pathobiology, natural history, and response to therapy of the diverse causes of secondary ITP differ from each ...
Douglas B. Cines +2 more
openaire +2 more sources
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon +6 more
wiley +1 more source
Thrombocytopenia could appear during pregnancy, in up to 8–10% of the cases, where 3–5% is related to an autoimmune process so-called immune thrombocytopenia (ITP). We present a 34-year-old woman debuted at 13 weeks gestation, with a platelet count of 19
Rodriguez Nuñez Rosa María +3 more
doaj +1 more source
Occult Hemorrhage in Immune Thrombocytopenia
Assessing clinical bleeding in patients with immune thrombocytopenia (ITP) and predicting future risk of major hemorrhage has proven to be a complicated task given the heterogeneity in bleeding manifestations. Although bleeding scales have been used for this purpose, they fail to account for occult or subclinical hemorrhage.
George R. Buchanan, Adolfo Flores
openaire +3 more sources
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner +7 more
wiley +1 more source
Immune thrombocytopenia in lymphoproliferative diseases [PDF]
BR Kaden, WF Rosse, TW Hauch
openalex +1 more source
Recent advances in the mechanisms and treatment of immune thrombocytopenia
D. Provan, J. Semple
semanticscholar +1 more source
Drug-Induced Immune Thrombocytopenia
Thrombocytopenia can have several causes, including the use of certain drugs. The mechanism behind drug-induced thrombocytopenia is either a decrease in platelet production (bone marrow toxicity) or an increased destruction (immune-mediated thrombocytopenia).
Patricia M. L. A. van den Bemt +3 more
openaire +4 more sources
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea +5 more
wiley +1 more source
Introduction: Platelets are cells that play an important role in the first phase of hemostasis, where the clot plug is formed. Disorders in the number or function of platelets can lead to bleeding.
Yasemin Denkboy Öngen, Birol Baytan
doaj +1 more source

